Aptose Biosciences Granted Nasdaq Compliance Extension - TipRanks
| APS Stock | CAD 0.37 0.01 2.78% |
About 55% of Aptose Biosciences' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Aptose Biosciences suggests that some traders are interested. Aptose Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Aptose Biosciences. Many technical investors use Aptose Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aptose |
Aptose Biosciences Granted Nasdaq Compliance Extension TipRanks
Read at news.google.com
 |
Aptose Biosciences Fundamental Analysis
We analyze Aptose Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Aptose Biosciences is rated third in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Aptose Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aptose Biosciences stock to make a market-neutral strategy. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics with similar companies.
Peers
Aptose Biosciences Related Equities
| APS | Aptose Biosciences | 2.78 | ||||
| ERE-UN | European Residential | 1.32 | ||||
| XEG | IShares SPTSX | 0.78 | ||||
| XHB | IShares Canadian | 0.20 | ||||
| RUDB | RBC Discount | 0.09 | ||||
| ALA-PA | Altagas Cum | 1.73 |
Check out Aptose Biosciences Hype Analysis, Aptose Biosciences Correlation and Aptose Biosciences Performance. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.